ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Los Angeles, CA, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Los Angeles, California, United States and 44 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Pasadena, California, United States and 26 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Riverside, California, United States and 24 other locations

The purpose of this study is to assess the safety and tolerability of aleniglipron at doses up to 240 mg once daily (QD) in participants with T2DM wh...

Enrolling
Obesity Type 2 Diabetes Mellitus
Weight Loss
Drug: Placebo
Drug: Aleniglipron

Phase 2

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Lomita, California, United States and 16 other locations

Locations recently updated

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: KAI-9531
Drug: Placebo

Phase 3

Kailera

Northridge, California, United States and 19 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Los Angeles, California, United States and 89 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Not yet enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Long Beach, California, United States and 45 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Procedure: Sham Comparator
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Los Angeles, California, United States and 87 other locations

Patients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic r...

Enrolling
Diabetic Macular Edema (DME)
Drug: Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

Phase 4

Retina Consultants of Orange County

Fullerton, California, United States

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Newport Beach, California, United States and 59 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems